GlassScriptPhysician profile
Graham Davis
NPI 1114423811
$1,286.87
in general payments reported to CMS, 2019-2025
4 companies · $929 in 2025
The $929 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.95 · 2022: $153 · 2023: $186 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Travel and Lodging: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.36 |
| Travel and Lodging | $536.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $928.85 | 2025 | |
| W. L. Gore & Associates, INC. | $186.40 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Integra Lifesciences Corporation | $152.67 | 2022 | |
| Abbott Laboratories | $18.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graham Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.